Keywords: MolMed, Telethin, Research, Rare diseases

MolMed and Fondazione Telethon to collaborate on gene therapy for six rare diseases

Article | 30 March 2011

Print This

Italian biotech firm MolMed SpA (Milan: MLM) and the charity Fondazione Telethon have entered into an accord to develop and ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in